Ultrasound vendors Acuson and Siemens Ultrasound are the latest recipients of contracts from HMO Kaiser Permanente. After naming Acuson to be its sole provider of radiology and vascular ultrasound systems (SCAN 9/3/97), Kaiser has also named Acuson its
Ultrasound vendors Acuson and Siemens Ultrasound are the latest recipients of contracts from HMO Kaiser Permanente. After naming Acuson to be its sole provider of radiology and vascular ultrasound systems (SCAN 9/3/97), Kaiser has also named Acuson its selected vendor for cardiac ultrasound systems in adult, pediatric, intraoperative, and stress echocardiography applications.
As part of the two-year, sole-source agreement, Kaiser will buy replacement and additional Sequoia C256 and Aspen echocardiography systems over the term of the contract. The agreement also includes two single-year extension options, according to Mountain View, CA-based Acuson. Kaiser's previous preferred vendor for cardiac ultrasound was Hewlett-Packard.
In another Kaiser contract, the HMO awarded Siemens Ultrasound a two-year agreement to be its sole provider of ob/gyn, emergency-room, and urology ultrasound scanners. Under the terms of the deal, Kaiser will purchase multiple Sonoline Prima systems. The contract is valued at $1 million per year, according to the Issaquah, WA-based firm.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.